3Afonso LCC,Scharton TM,Vieira LQ,et al.The adjuvant effect of interleukin-12 in a vaccine against Leishmania major[J].Science,1994,263:235-237.
4Wynn TA,Cheever AW,Jankovic D,et al.An IL-12 based vaccination method for preventing fibrosis induced by Schistosome infection [J].Nature,1995,376(17):594-596.
5Su Z,Tam MF,Jankovic D,et al.Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice[J].Infect Immunol,2003,71(9):5178-5187.
6Hunter RL,Kidd MR,Olsen MR,et al.Induction of long lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants[J].J Immunol,1995,154:1762-1769.
7Hagen TLM,Sulzer AJ,Kidd MR,Lal AA,et al.Role of adjuvants in the modulation of antibody isotype,specificity,and induction of protection by whole blood-stage plasmodium yoelii vaccines [J].J Immunol,1993,12:7077-7085.
8Francoise MA,Luc DL.Adjuvants:current status,clinical perspectives and future prospects[J].Immunol Today,1993,14(6):281-284.
9D′Andrea A,Rengaraju M,Valiante NM,et al.Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells[J].J Exp Med,1992,176:1387-1398.
